Immunoregulatory function of PIR-A/B+ DCs in the inflammatory responses of dextran sodium sulfate-induced colitis

Journal of Gastroenterology

Volumn 49, Issue 10, 2014, Pages 1367-1377

  Kurishima, Akiko ^a   Inaba, Muneo ^a   Sakaguchi, Yutaku ^a   Fukui, Toshiro ^a   Uchida, Kazushige ^a   Nishio, Akiyoshi ^a   Nomura, Shosaku ^a   Okazaki, Kazuichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Dendritic cells; Dextran sulfate sodium; Inflammatory bowel disease; Paired immunoglobulin like receptors

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA; IMMUNOGLOBULIN RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; FEMALE; GENETIC ANALYSIS; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATION; LAMINA PROPRIA; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; STEADY STATE; T LYMPHOCYTE ACTIVATION; THERAPY EFFECT; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMICALLY INDUCED; COLON; DISEASE MODEL; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; MIXED LYMPHOCYTE CULTURE; PATHOLOGY; PROCEDURES; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; COLON; DENDRITIC CELLS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTE CULTURE TEST, MIXED; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, IMMUNOLOGIC;

EID: 84919413530     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0879-x     Document Type: Article

References (38)

1. Shi XZ, Winston JH, Sarna SK. Differential immune and genetic responses in rat models of Crohn’s colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol. 2011;300:G41–51.
2. Melger S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms. Am J Physiol Gastrointest Liver Physiol. 2005;288:G1328–38.
3. Boismenu R, Chen Y. Insight from mouse models of colitis. J Leukoc Biol. 2000;67:267–78.
4. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702.
5. Whittem CG, Williams AD, Williams CS. Murine colitis modeling using dextran sulfate sodium (DSS). J Vis Exp. 2010;35:pii 1652.
6. Hochrein H, O’Keeffe M, Luft T, Vandenabeele S, Grumont RJ, Maraskovsky E, et al. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med. 2000;192:823–33.
7. Steinman RM, Hawiger D, Liu K, Bonnyay D, Mahnke K, Iyoda T, et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann N Y Acad Sci. 2003;987:15–25.
8. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006;311:17–56.
9. Sato K, Yamashita N, Baba M, Matsuyama T. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood. 2003;101:3581–9.
10. Fujita S, Sato Y, Sato K, Eizumi K, Fukaya T, Kubo M, et al. Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+ CD25+ Foxp3+ regulatory T cells. Blood. 2007;110:3793–803.
11. Cho JH, Abraham C. Inflammatory bowel disease genetics: Nod2. Ann Rev Med. 2007;58:410–6.
12. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.
13. Fritz JH, Girardin SE, Fitting C, Werts C, Mengin-Lecreulx D, Caroff M, et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol. 2005;35:2459–70.
14. Berndt BE, Zhang M, Chen GH, Huffnagle GB, Kao JY. The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J Immunol. 2007;179:6255–62.
15. Hoshino S, Inaba M, Iwai H, Ito T, Li M, Gershwin ME, et al. The role of dendritic cell subsets in 2,4,6-trinitrobenzene sulfonic acid-induced ileitis. J Autoimmun. 2010;34:380–9.
16. Hoshino S, Kurishima A, Inaba M, Ando Y, Fukui T, Uchida K, et al. Amelioration of 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by immunoregulatory dendritic cells. J Gastroenterol. 2011;46:1368–81.
17. Nakano H, Yanagita M, Gunn MD. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med. 2001;194:1171–8.
18. Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun CM, Belkaid Y, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J Exp Med. 2007;204:1757–64.
19. Danese S. Nonimmune cells in inflammatory bowel disease: from victim to villain. Trends Immunol. 2008;29:555–64.
20. Rescigno M, Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J Clin Invest. 2009;119:2441–50.
21. Abe K, Nguyen KP, Fine SD, Mo JH, Shen C, Shenouda S, et al. Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells. Proc Natl Acad Sci USA. 2007;104:17022–7.
22. Fahlén L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA, et al. T cells that cannot respond to TGF-β escape control by CD4+ CD25+ regulatory T cells. J Exp Med. 2005;201:737–46.
23. Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737–42.
24. Matteoli G, Mazzini E, Iliev ID, Mileti E, Fallarino F, Puccetti P, et al. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut. 2010;59:595–604.
25. Suri-Payer E, Cantor H. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4+ CD25+ T cells. J Autoimmun. 2001;16:115–23.
26. Bilsborough J, George TC, Norment A, Viney JL. Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology. 2003;108:481–92.
27. Kubagawa H, Burrows PD, Cooper MD. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA. 1997;94:5261–6.
28. Hayami K, Fukuta D, Nishikawa Y, Yamashita Y, Inui M, Ohyama Y, et al. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J Biol Chem. 1997;272:7320–7.
29. Ujike A, Takeda K, Nakamura A, Ebihara S, Akiyama K, Takai T. Impaired dendritic cell maturation and increased TH2 responses in PIR-B−/− mice. Nat Immunol. 2002;3:542–8.
30. Castro-Sánchez P, Martín-Villa JM. Gut immune system and oral tolerance. Br J Nutr. 2013;109(Suppl 2):S3–11.
31. Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, et al. Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol. 2004;24:74–85.
32. Hruz P, Eckmann L. Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn’s disease. Swiss Med Wkly. 2010;140:w13135.
33. Man SK, Kaakoush NO, Mitcell HM. The role of bacteria and pattern-recognition receptors in Crohn’s disease. Nat Rev Gastroenterol Hepatol. 2011;8:152–68.
34. Ardizzone S, Cassinotti A, Manes G, Porro GB. Immunomodulators for all patients with inflammatory bowel disease? Ther Adv Gastroenterol. 2010;3:31–42.
35. Fiorino G, Szabò H, Fries W, Malesci A, Peyrin-Biroulet L, Danese S. Adalimumab in Crohn’s disease: tips and tricks after 5 years of clinical experience. Curr Med Chem. 2011;18:1230–8.
36. Nielsen OH, Seidelin JB, Munck LK, Rogler G. Use of biological molecules in the treatment of inflammatory bowel disease. J Intern Med. 2011;2011(270):15–28.
37. Scherl EJ, Kumar S, Warren RU. Review of the safety and efficacy of ustekinumab. Ther Adv Gastroenterol. 2010;3:321–8.
38. Ghosh S, Panaccione R. Anti-adhesion molecule therapy for inflammatory bowel disease. Ther Adv Gastroenterol. 2010;3:239–58.